[1] Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver:a collective review[J]. Journal of Gastroenterology, 1994,29(1):95-105.
[2] Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma:diagnostic findings and management[J]. International Journal of Hepatology, 2012,2012:410781.
[3] Yang X, Li A, Wu M. Hepatic angiomyolipoma:clinical, imaging and pathological features in 178 cases[J]. Medical Oncology, 2013,30(1):416.
[4] Chang Z, Zhang J M, Ying J Q, et al. Characteristics and treatment strategy of hepatic angiomyolipoma:a series of 94 patients collected from four institutions[J]. Journal of Gastrointestinal and Liver Diseases, 2011,20(1):65-69.
[5] Liu W, Meng Z, Liu H, et al. Hepatic epithelioid angiomyolipoma is a rare and potentially severe but treatable tumor:a report of three cases and review of the literature[J]. Oncology Letters, 2016,11(6):3669-3675.
[6] Högemann D, Flemming P, Kreipe H, et al. Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma[J]. European Radiology, 2001,11(8):1389-1395.
[7] Takayama Y, Moriura S, Nagata J, et al. Hepatic angiomyolipoma:radiologic and histopathologic correlation[J]. Abdominal Imaging, 2002,27(2):180-183.
[8] Li R, Zhang X, Hua X, et al. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas[J]. Abdominal Imaging, 2010,35(6):676-682.
[9] Wang Z, Xu H X, Xie X Y, et al. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound[J]. The British Journal of Radiology, 2010,83(989):411-418.
[10] Tsui W M, Colombari R, Portmann B C, et al. Hepatic angiomyolipoma:a clinicopathologic study of 30 cases and delineation of unusual morphologic variants[J]. The American Journal of Surgical Pathology, 1999,23(1):34-48.
[11] Li R, Tang C L, Cai P, et al. Comparison of CT and contrast-enhanced ultrasound findings in hepatic angiomyolipoma with pathological correlations[J]. Abdominal Radiology, 2016,41(2):248-256.
[12] Flemming P, Lehmann U, Becker T, et al. Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype[J]. Hepatology, 2000,32(2):213-217.
[13] Fetsch P A, Fetsch J F, Marincola F M, et al. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45:additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor[J]. Modern Pathology, 1998,11(8):699-703.
[14] Yen Y H, Wang J H, Lu S N, et al. Contrast-enhanced ultrasonography in hepatic angiomyolipoma[J]. Journal of Ultrasound in Medicine, 2005,24(6):855-859.
[15] Wei H T, Liu H, Chen Y H, et al. The histopathological features and CT/MRI imaging performances in hepatic angiomyolipoma patients[J]. Annals of Hepatology, 2017,16(5):759-764.
[16] Petrolla A A, Xin W. Hepatic angiomyolipoma[J]. Archives of Pathology & Laboratory Medicine, 2008,132(10):1679-1682.
[17] Marrero J A, Ahn J, Reddy R K.ACG clinical guideline:the diagnosis and management of focal liver lesions[J]. The American Journal of Gastroenterology, 2014,109(9):1328-1347.
[18] Li R, Tang C L, Zhang Y, et al. Diagnosis of hepatic angiomyolipoma by combination of baseline and contrast-enhanced ultrasound-a prospective study in non-cirrhotic patients[J]. PloS One, 2015,10(7):e0132290.
[19] Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver:significance of CT and MR dynamic study[J]. Abdominal Imaging, 1998,23(5):520-526.
[20] Yeh H C, Klion F M, Thung S N, et al. Angiomyolipoma:ultrasonographic signs of lipomatous hepatic tumors[J]. Journal of Ultrasound in Medicine,1996,15(4):337-342.
[21] Goodman Z D, Ishak K G. Angiomyolipomas of the liver[J].The American Journal of Surgical Pathology, 1984,8(10):745-750.
[22] 徐少真, 潘江峰. 肝血管平滑肌脂肪瘤的MRI与CT影像表现[J]. 医学影像学杂志, 2016,26(4):658-661. Xu S Z, Pan J F. MRI and CT imaging manifestations of hepatic angiomyolipomas[J]. Journal of Medical Imaging, 2016,26(4):658-661.
[23] Prasad S R, Wang H, Rosas H, et al. Fat-containing lesions of the liver:radiologic-pathologic correlation[J]. Radiographics,2005,25(2):321-331.
[24] Anysz-Grodzicka A, Pacho R, Grodzicki M, et al. Angiomyolipoma of the liver:analysis of typical features and pitfalls based on own experience and literature[J]. Clinical Imaging, 2013,37(2):320-326.
[25] Cai P Q, Wu Y P, Xie C M, et al. Hepatic angiomyolipoma:CT and MR imaging findings with clinical-pathologic comparison[J]. Abdominal Imaging, 2013,38(3):482-489.
[26] Wei R X, Wang W P, Ding H, et al. Hepatic angiomyolipoma:contrast patterns with SonoVue-enhanced real-time gray-scale ultrasonography[J]. Asian Pacific Journal of Cancer Prevention, 2012,13(2):493-497.
[27] Ren N, Qin L X, Tang Z Y, et al. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases[J]. World Journal of Gastroenterology, 2003,9(8):1856-1858.
[28] Bartolotta T V, Runza G, Minervini M, et al. Hepatic angiomyolipoma:contrast-enhanced pulse inversion US in a case[J]. La Radiologia Medica, 2003,105(5-6):514-518.
[29] Leen E, Ceccotti P, Kalogeropoulou C, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography[J]. American Journal of Roentgenology, 2006,186(6):1551-1559.
[30] Ricci P, Laghi A, Cantisani V, et al. Contrast-enhanced sonography with SonoVue:enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI[J].American Journal of Roentgenology, 2005,184(3):821-827.
[31] Claudon M, Dietrich C F, Choi B I, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012:a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS[J].Ultrasound in Medicine & Biology, 2013,39(2):187-210. |